| 6FMD | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | ACT, CL, DUH, FMN, GOL, ORO, PGE | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors., Sainas S, Pippione AC, Lupino E, Giorgis M, Circosta P, Gaidano V, Goyal P, Bonanni D, Rolando B, Cignetti A, Ducime A, Andersson M, Jarva M, Friemann R, Piccinini M, Ramondetti C, Buccinna B, Al-Karadaghi S, Boschi D, Saglio G, Lolli ML, J Med Chem. 2018 Jul 9. doi: 10.1021/acs.jmedchem.8b00373. PMID:29939742 | ||||||||||||||
| Data retrieval |
![]() |
| View 6FMD in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |